Bradley L Campbell Insider Trading $PGNX PROGENICS PHARMACEUTICALS INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Bradley L Campbell.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Bradley L Campbell. Bradley L Campbell is in PROGENICS PHARMACEUTICALS INC ($PGNX) and Director in PROGENICS PHARMACEUTICALS INC ($PGNX) and Chief Business Officer in AMICUS THERAPEUTICS INC ($FOLD) and Chief Operating Officer in AMICUS THERAPEUTICS INC ($FOLD) and SVP, Business Operations in AMICUS THERAPEUTICS INC ($FOLD) and VP, Business Development in AMICUS THERAPEUTICS INC ($FOLD) and VP, Business Operations in AMICUS THERAPEUTICS INC ($FOLD).

Bradley L Campbell in PROGENICS PHARMACEUTICALS INC

Trading Symbol: PGNX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Bradley L Campbell: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 23 2020
$PGNX Market Capitalization: $671.09M
$PGNX Previous Close: $9.53

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Bradley L Campbell in PROGENICS PHARMACEUTICALS INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, FOLD, PGNX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD5.7425,000143,5000
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD8.9925,000224,7500
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD5.7425,000143,5000
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD6.9520,000139,0000
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD8.9925,000224,7500
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD4.8928,000136,9200
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD6.9520,000139,0000
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorSellD0.0012,0000012 K to 0 (-100.00 %)
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorOption ExerciseD4.8928,000136,9200
Jun 23 2020PGNXPROGENICS PHARMACE ...Campbell Bradley LDirectorSellD0.0012,0000012 K to 0 (-100.00 %)
Jul 15 2019PGNXPROGENICS PHARMACE ...Campbell Bradley LOption ExerciseA5.7425,000143,50025,000
Jul 08 2019PGNXPROGENICS PHARMACE ...Campbell Bradley LOption ExerciseM4.8912,00058,6800
Jul 08 2019PGNXPROGENICS PHARMACE ...Campbell Bradley LBuyM4.8912,00058,68012,0000 to 12 K
Jun 14 2018PGNXPROGENICS PHARMACE ...Campbell Bradley LOption ExerciseA8.9925,000224,75025,000
Jun 15 2017PGNXPROGENICS PHARMACE ...Campbell Bradley LOption ExerciseA6.9520,000139,00020,000
Jun 15 2017PGNXPROGENICS PHARMACE ...Campbell Bradley LOption ExerciseA6.9520,000139,00020,000
Jun 09 2016PGNXPROGENICS PHARMACE ...Campbell Bradley LOption ExerciseA4.8940,000195,60040,000

Page:   1